FindTrial
Sign In

SERUM CREATINE PHOSPHOKINASE-MB AS PREDICTOR for UTERINE SCAR INTEGRITY

SERUM CREATINE PHOSPHOKINASE-MB LEVEL AS A PREDICTOR OF UTERINE SCAR INTEGRITY IN WOMEN UNDERGOING REPEAT CAESEREAN SECTION

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053575
Enrollment
650
Registered
2023-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O754- Other complications of obstetric surgery and procedures

Interventions

None listed

Sponsors

Vardhman Mahavir Medical College and Safdarjung Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA- 1. Pregnant females undergoing repeat LSCS. 2. Period of gestation = 28 weeks.

Exclusion criteria

Exclusion criteria: Antenatal women in active phase of labour. 2. Medical comorbidities like heart disease, hypothyroidism, chronic kidney disease, overt diabetes mellitus and chronic hypertension. 3. Known case of any musculoskeletal disorder like rhabdomyolysis, myositis, inflammatory myopathies, trauma, etc. 4. Patients on medications like daptomycin, statins and anti-retrovirals.

Design outcomes

Primary

MeasureTime frame
1.CPK-MB level in women undergoing repeat CS. 2.No of women undergoing repeat CS with an intact uterine scar.Timepoint: baseline—

Secondary

MeasureTime frame
..Timepoint: ..—

Countries

India

Contacts

Public ContactDr Shivam Yadav

Vardhman Mahavir Medical College and Safdarjung Hospital

dr_devya1@yahoo.co.in8860198440

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026